Accession PRJCA012882
Title Phase III trial of PD-1 antibody SR-1210 combined with pemetrexed plus carboplatin as first-line therapy in patients with advanced or metastatic non-squamous cell non-small cell lung cancer
Relevance Medical
Data types Clinical, imaging, biomarker data, etc
Organisms Homo sapiens
Description Phase III trial of PD-1 antibody SR-1210 combined with pemetrexed plus carboplatin as first-line therapy in patients with advanced or metastatic non-squamous cell non-small cell lung cancer
Sample scope Multiisolate
Release date 2022-10-31
Grants
Agency program Grant ID Grant title
NA NA NA NA
Submitter weiqing ge weiqing ge  (weiqing.ge@hengrui.com)
Organization Jiangsu Hengrui pharmaceutical Co.LTD
Submission date 2022-10-31

Project Data

Resource name Description